Edwards Lifesciences Corp (NYSE:EW) shares traded -0.47% lower at $70.20 on Wall Street last session.
EW stock price is now 3.04% away from the 50-day moving average and -11.34% away from the 200-day moving average. The market capitalization of the company currently stands at $41.40B.
On September 18, 2024, Jefferies Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $85 to quote $70, while ‘Daiwa Securities’ rates the stock as ‘Outperform’
In other news, BOBO DONALD E JR, CVP,Strategy/Corp Development sold 5,000 shares of the company’s stock on Nov 13 ’24. The stock was sold for $327,843 at an average price of $65.57. Upon completion of the transaction, the CVP,Strategy/Corp Development now directly owns 46,936 shares in the company, valued at $3.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 13 ’24, Officer BOBO DONALD E JR bought 15,000 shares of the business’s stock. A total of $983,529 was incurred on buying the stock at an average price of $65.57. A total of 1.70% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $58.93 and a high of $96.12. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 3.46, and a quick ratio of 2.89. According to the stock market information, the enterprise value for the company is $37730361344, which is based on a 10.13 price-to-earnings ratio, a 1.45 price-to-earnings-growth ratio, and a beta of 1.13. The fifty day moving average price for EW is $68.07 and a two-hundred day moving average price translates $79.26185 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for 2024-09-30. The net profit margin was 70.82% and return on equity was 17.93% for EW. The company reported revenue of $1.35 billion for the quarter, compared to $1.24 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.93 percent.
